-
1
-
-
0242467375
-
Botulinumtoxin A (Botox cosmetic): A review of its use in the treatment of glabellar frown lines
-
Frampton JE, Easthope SE. Botulinumtoxin A (Botox cosmetic): a review of its use in the treatment of glabellar frown lines. Am J Clin Dermatol. 2003;4: 709-25.
-
(2003)
Am J Clin Dermatol.
, vol.4
, pp. 709-725
-
-
Frampton, J.E.1
Easthope, S.E.2
-
2
-
-
0141973899
-
"M" marks the spot: Update on treatment guidelines for botulinum toxin type A for the periocular area
-
Matarasso S, Matarasso A. "M" marks the spot: update on treatment guidelines for botulinum toxin type A for the periocular area. Plast Reconstr Surg. 2003;112:1470-2.
-
(2003)
Plast Reconstr Surg.
, vol.112
, pp. 1470-1472
-
-
Matarasso, S.1
Matarasso, A.2
-
3
-
-
34548308502
-
Clostridium botulinum type A toxin for the treatment of upper face animation lines: An Iranian experience
-
Farahvash MR, Arad S. Clostridium botulinum type A toxin for the treatment of upper face animation lines: an Iranian experience. J Cosmet Dermatol. 2007;6:152-8.
-
(2007)
J Cosmet Dermatol.
, vol.6
, pp. 152-158
-
-
Farahvash, M.R.1
Arad, S.2
-
4
-
-
57349190038
-
Subunit stoichiometry of the Clostridium botulinum type A neurotoxin complex determined using denaturing capillary electrophoresis
-
Lietzow MA, Gielow ET, Le D, Zhang J, Verhagen MF. Subunit stoichiometry of the Clostridium botulinum type A neurotoxin complex determined using denaturing capillary electrophoresis. Protein J. 2008;27:420-5.
-
(2008)
Protein J.
, vol.27
, pp. 420-425
-
-
Lietzow, M.A.1
Gielow, E.T.2
Le, D.3
Zhang, J.4
Verhagen, M.F.5
-
5
-
-
43049106466
-
Comparison of type a botulinum toxin products in clinical use
-
Pickett A, Caird D. Comparison of type a botulinum toxin products in clinical use. J Clin Pharm Ther. 2008;33:327-8.
-
(2008)
J Clin Pharm Ther.
, vol.33
, pp. 327-328
-
-
Pickett, A.1
Caird, D.2
-
6
-
-
68249135346
-
Different botulinum toxins and their specifications
-
Beylot C. Different botulinum toxins and their specifications. Ann Dermatol Venereol. 2009; 136(Suppl 4):S77-85.
-
(2009)
Ann Dermatol Venereol.
, vol.136
, Issue.SUPPL. 4
-
-
Beylot, C.1
-
8
-
-
70349666911
-
Efficacy and safety of botulinum toxin type A in the treatment of lateral crow's feet: Double-blind, placebo-controlled doseranging study
-
Ascher B, Rzany B, Grover R. Efficacy and safety of botulinum toxin type A in the treatment of lateral crow's feet: double-blind, placebo-controlled doseranging study. Dermatol Surg. 2009;35:1478-86.
-
(2009)
Dermatol Surg.
, vol.35
, pp. 1478-1486
-
-
Ascher, B.1
Rzany, B.2
Grover, R.3
-
10
-
-
33750808473
-
Comparison of two formulations of botulinum toxin type A for the treatment of glabellar lines: A double-blind, randomized study
-
Lowe P, Patnaik R, Lowe N. Comparison of two formulations of botulinum toxin type A for the treatment of glabellar lines: a double-blind, randomized study. J Am Acad Dermatol. 2006;55: 975-80.
-
(2006)
J Am Acad Dermatol.
, vol.55
, pp. 975-980
-
-
Lowe, P.1
Patnaik, R.2
Lowe, N.3
-
11
-
-
0142186663
-
Follow-up: Botulinum toxin
-
Plastic Surgery Educational Foundation DATA Committee
-
Matarasso A, Chia C, Plastic Surgery Educational Foundation DATA Committee. Follow-up: botulinum toxin. Plast Reconstr Surg. 2003;112(5 Suppl):62S-5S.
-
(2003)
Plast Reconstr Surg.
, vol.112
, Issue.5 SUPPL.
-
-
Matarasso, A.1
Chia, C.2
-
12
-
-
67649878802
-
The Efficacy and safety of a new U.S. botulinum toxin type A in the retreatment of glabellar lines following open-label treatment
-
Available at Accessed October 18, 2010
-
RubinM, Dover JS, Glogau RG, et al. The Efficacy and safety of a new U.S. botulinum toxin type A in the retreatment of glabellar lines following open-label treatment. J Drugs Dermatol. 2009;8(5):439-44. Available at http://findarticles.com/p/articles/mi_ m0PDG/is_5_8/ai_n32147651/. Accessed October 18, 2010.
-
(2009)
J Drugs Dermatol.
, vol.8
, Issue.5
, pp. 439-444
-
-
Rubin, M.1
Dover, J.S.2
Glogau, R.G.3
-
14
-
-
0041912475
-
Reproducibility of a four-point clinical severity score for glabellar frown lines
-
Honeck P, Weiss C, Sterry W, Rzany B. Reproducibility of a four-point clinical severity score for glabellar frown lines. Br J Dermatol. 2003;149:306-10.
-
(2003)
Br J Dermatol.
, vol.149
, pp. 306-310
-
-
Honeck, P.1
Weiss, C.2
Sterry, W.3
Rzany, B.4
-
15
-
-
33750033869
-
Reproducibility of two four-point clinical severity scores for lateral canthal lines (crow's feet)
-
Hund T, Ascher B, Rzany B. Reproducibility of two four-point clinical severity scores for lateral canthal lines (crow's feet). Dermatol Surg. 2006;32: 1256-60.
-
(2006)
Dermatol Surg.
, vol.32
, pp. 1256-1260
-
-
Hund, T.1
Ascher, B.2
Rzany, B.3
-
16
-
-
80053027080
-
Rapid Onset of response and patient-reported outcomes after onabotulinumtoxinA treatment of moderate-tosevere glabellar lines
-
Beer KR, Boyd C, Patel R, et al. Rapid Onset of response and patient-reported outcomes after onabotulinumtoxinA treatment of moderate-tosevere glabellar lines. J Drugs Dermatol. 2011;10: 39-44.
-
(2011)
J Drugs Dermatol.
, vol.10
, pp. 39-44
-
-
Beer, K.R.1
Boyd, C.2
Patel, R.3
-
17
-
-
77949883132
-
Dosing, efficacy and safety plus the use of computerized photography for botulinum toxins type A for upper facial lines
-
Lowe NJ, Shah A, Lowe PL, Patnaik R. Dosing, efficacy and safety plus the use of computerized photography for botulinum toxins type A for upper facial lines. J Cosmet Laser Ther. 2010;12:106-11.
-
(2010)
J Cosmet Laser Ther.
, vol.12
, pp. 106-111
-
-
Lowe, N.J.1
Shah, A.2
Lowe, P.L.3
Patnaik, R.4
|